pentobarbital will minimize the level or effect of imatinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Importance Unidentified.

pentobarbital will lower the level or effect of elbasvir/grazoprevir by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. The therapeutic outcome of elbasvir/grazoprevir may very well be lessened if coadministered with potent CYP3A inducers and is particularly hence contraindicated.

pentobarbital will reduce the extent or outcome of fosaprepitant by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check.

pentobarbital will minimize the extent or impact of vardenafil by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of.

Monitor Closely (one)pentobarbital will decrease the level or effect of osilodrostat by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

pentobarbital will minimize the extent or influence of fentanyl intranasal by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep track of Closely. Coadministration of fentanyl with CYP3A4 inducers could lead on to your lower in fentanyl plasma concentrations, lack of efficacy or, possibly, enhancement of the withdrawal syndrome within a patient who may have designed physical dependence to fentanyl.

pentobarbital will lessen the level or effect of quinidine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.

Phenytoin and barbiturate blood ranges need to be monitored a lot more routinely if provided concurrently; influence of barbiturates on phenytoin metabolism reported for being variable; sodium valproate and valproic acid show up to decrease barbiturate metabolism; check barbiturate blood degrees and make appropriate dosage adjustments as required

pentobarbital will decrease the level or impact of conjugated estrogens, vaginal by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on.

pentobarbital will decrease the extent or impact of dexamethasone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

Observe Intently (1)pentobarbital will reduce the level or influence of mestranol by influencing hepatic/intestinal enzyme CYP3A4 metabolism.

pentobarbital will minimize the extent or effect of tramadol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe. Lowered AUC of tramadol and also the Energetic here metabolite (O-desmethyltramadol) when coadministered with potent CYP3A4 and CYP2B6 inducers

pentobarbital will lower the extent or impact of propafenone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Small/Importance Unknown.

pentobarbital will reduce the extent or influence of paclitaxel by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Importance Unidentified.